Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Operating Leases (2019 - 2025)

Biomerica's Operating Leases history spans 7 years, with the latest figure at $373000.0 for Q3 2025.

  • For Q3 2025, Operating Leases changed 0.0% year-over-year to $373000.0; the TTM value through Aug 2025 reached $373000.0, changed 0.0%, while the annual FY2025 figure was $100000.0, 78.21% down from the prior year.
  • Operating Leases for Q3 2025 was $373000.0 at Biomerica, up from $100000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $1.5 million in Q4 2021 and bottomed at $100000.0 in Q2 2025.
  • The 5-year median for Operating Leases is $937000.0 (2023), against an average of $877398.9.
  • The largest annual shift saw Operating Leases rose 6.83% in 2022 before it crashed 78.21% in 2025.
  • A 5-year view of Operating Leases shows it stood at $1.5 million in 2021, then dropped by 16.91% to $1.2 million in 2022, then fell by 24.92% to $937000.0 in 2023, then plummeted by 69.69% to $284000.0 in 2024, then surged by 31.34% to $373000.0 in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Operating Leases are $373000.0 (Q3 2025), $100000.0 (Q2 2025), and $193000.0 (Q1 2025).